Conduit Pharmaceuticals Inc. - Asset Resilience Ratio

Latest as of September 2025: 11.58%

Conduit Pharmaceuticals Inc. (CDT) has an Asset Resilience Ratio of 11.58% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CDT free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

$990.00K

Cash + Short-term Investments

Total Assets

$8.55 Million

All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Conduit Pharmaceuticals Inc.'s Asset Resilience Ratio has changed over time. See debt-free asset ratio of Conduit Pharmaceuticals Inc. to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Conduit Pharmaceuticals Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Conduit Pharmaceuticals Inc. (CDT) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$990.00K	11.58%
Total Liquid Assets	$990.00K	11.58%

Asset Resilience Insights

Moderate Liquidity: Conduit Pharmaceuticals Inc. has 11.58% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Conduit Pharmaceuticals Inc. Industry Peers by Asset Resilience Ratio

Compare Conduit Pharmaceuticals Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Conduit Pharmaceuticals Inc. (None–None)

The table below shows the annual Asset Resilience Ratio data for Conduit Pharmaceuticals Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Conduit Pharmaceuticals Inc.

NASDAQ:CDT USA Biotechnology

Market Cap

$3.37 Million

Market Cap Rank

#29280 Global

#5921 in USA

Share Price

$0.69

Change (1 day)

-3.46%

52-Week Range

$0.39 - $9.35

All Time High

$16.99